- Home
- DYN vs CMPO Comparison
DYN vs CMPO Comparison
Compare DYN & CMPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- CMPO
- Stock Information
- Founded
- DYN 1984
- CMPO 2000
- Country
- DYN United States
- CMPO United States
- Employees
- DYN N/A
- CMPO N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- CMPO Finance: Consumer Services
- Sector
- DYN Health Care
- CMPO Finance
- Exchange
- DYN Nasdaq
- CMPO Nasdaq
- Market Cap
- DYN 1.9B
- CMPO 2.1B
- IPO Year
- DYN 2020
- CMPO N/A
- Fundamental
- Price
- DYN $22.58
- CMPO $19.86
- Analyst Decision
- DYN Strong Buy
- CMPO Strong Buy
- Analyst Count
- DYN 14
- CMPO 6
- Target Price
- DYN $34.93
- CMPO $19.67
- AVG Volume (30 Days)
- DYN 3.0M
- CMPO 528.0K
- Earning Date
- DYN 10-28-2025
- CMPO 11-10-2025
- Dividend Yield
- DYN N/A
- CMPO N/A
- EPS Growth
- DYN N/A
- CMPO N/A
- EPS
- DYN N/A
- CMPO N/A
- Revenue
- DYN N/A
- CMPO $267,817,999.00
- Revenue This Year
- DYN N/A
- CMPO $10.21
- Revenue Next Year
- DYN N/A
- CMPO $8.45
- P/E Ratio
- DYN N/A
- CMPO N/A
- Revenue Growth
- DYN N/A
- CMPO N/A
- 52 Week Low
- DYN $6.36
- CMPO $9.24
- 52 Week High
- DYN $35.68
- CMPO $21.16
- Technical
- Relative Strength Index (RSI)
- DYN 74.06
- CMPO 49.29
- Support Level
- DYN $23.05
- CMPO $19.43
- Resistance Level
- DYN $25.00
- CMPO $20.74
- Average True Range (ATR)
- DYN 1.02
- CMPO 0.73
- MACD
- DYN 0.72
- CMPO -0.09
- Stochastic Oscillator
- DYN 78.24
- CMPO 38.05
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About CMPO CompoSecure Inc.
CompoSecure Inc is engaged in designing and manufacturing premium financial cards. The Company's metal payment card technology and Arculus security and authentication capabilities deliver premium branded experiences which enable people to access and use their assets, and ensure trust at the point of a transaction. Its products include Metal Cards and Arculus, a digital security platform. It has two reportable segments: Payment Card and Arculus.